Biotech

Firmenich Unveils Innovative Natural Solution to Recreate Meat-like Juiciness in Plant-based Alternatives

2021-05-18 20:00 1799

GENEVA, May 18, 2021 /PRNewswire/ -- Firmenich, the world's largest privately owned fragrance and taste company, is proud to announce the launch of Dynarome® SR, its proprietary, natural, Sustained Release technology designed to deliver an even more authentic meat experience in plant-based analog...

Nanoform's final clinical results confirm value proposition to the pharma industry

2021-05-18 13:48 1136

HELSINKI, Finland, May 18, 2021 /PRNewswire/ -- Nanoform Finland Plc ("Nanoform "), an innovative nanoparticle medicine enabling company, today announced the completion and final results of its clinical study. The primary, secondary and optional exploratory objectives of the study were all met. Th...

Clover Announces Positive Preclinical Data for Second-Generation Protein-Based COVID-19 Vaccine Candidate Demonstrating Broad Neutralization Against Variants of Concern

2021-05-18 11:50 2327

* The publication is available as a pre-print on bioRxiv * Preclinical data demonstrates that a modified B.1.351 S-Trimer vaccine candidate induces broad neutralization against both the original SARS-CoV-2 strain and variants of concern (VoC) including the South African variant * A single bo...

Mycenax becomes Taiwan's first CDMO company to complete the CHO-S and CHOZN GS Cell Line Development with the Beacon(R) Optofluidic System

2021-05-18 10:32 12825

TAIPEI, May 18, 2021 /PRNewswire/ -- Mycenax (TWSE: 4726) becomes one of the first CDMO companies inAsia to adapt the Beacon Optofluidic system to cell line development services. Mycenax adopted Beacon® Optofluidic System, a high throughput selection system for single-cell cloning and quantifica...

Hummingbird Bioscience Raises US$125 Million in Series C Financing

2021-05-18 09:35 2289

* Investment round led by Novo Holdings, joined by a syndicate of international biotech investors * Proceeds will support advancement of Hummingbird's lead assets in clinical trials and building of its next-generation portfolio of precision therapeutics * Kenneth Harrison from Novo Ventures ...

JA Worldwide Inducts 2021 Laureates into the Global Business Hall of Fame

2021-05-18 04:46 1270

BOSTON, May 18, 2021 /PRNewswire/ -- The Global Business Hall of Fame, presented by JA Worldwide, features entrepreneurs and business leaders spanning the last two centuries. From the inventor of blue jeans to the co-founder of one of the world's leading biotech companies, visitors to the digital...

JA Worldwide Inducts 2021 Laureates into the Global Business Hall of Fame

2021-05-18 01:10 1397

BOSTON, May 17, 2021 /PRNewswire/ -- The Global Business Hall of Fame, presented by JA Worldwide, features entrepreneurs and business leaders spanning the last two centuries. From the inventor of blue jeans to the co-founder of one of the world's leading biotech companies, visitors to the digital...

EpiVax Identifies T cell Epitopes critical to robust T cell immune response in SARS-CoV-2 , Results Published in NPJ Vaccines

2021-05-17 20:54 1659

PROVIDENCE, R.I., May 17, 2021 /PRNewswire/ -- EpiVax, Inc. ("EpiVax") announces the publication"Highly conserved, non-human-like, and cross-reactive SARS-CoV-2 T cell epitopes for COVID-19 vaccine design and validation" in NPJ Vaccines. This research identifies peptide epitopes associated with T...

Antengene and Calithera Biosciences Enter into Worldwide Exclusive License Agreement to Develop and Commercialize CD73 Inhibitor CB-708 (ATG-037)

2021-05-17 20:35 3263

SHANGHAI and SOUTH SAN FRANCISCO, Calif., May 17, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in he...

INOVIO Announces Appointment Of Roger Dansey, M.D., to its Board of Directors

2021-05-17 20:00 3463

Dr. Dansey, Seagen's Chief Medical Officer, brings extensive expertise in immuno-oncology and drug development Appointment of industry leader in drug development expands the Board's diverse industry, clinical development, research and commercialization expertise PLYMOUTH MEETING, Pa., May 17, 20...

Antengene Announces the Completion of the Quantitative and Systems Pharmacology Modeling for ATG-101 in Preparation for First-in-Human Trial

2021-05-17 08:00 2489

SHANGHAI and HONG KONG, May 17, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in hematology and onc...

China Pharma Holdings, Inc. Reports 33% YoY Increase in First Quarter 2021 Revenue

2021-05-15 04:30 9428

HAIKOU, China, May 14, 2021 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), a specialty pharmaceutical company, today announced financial results for the quarter ended March 31, 2021. Revenue increased by 33.7% to $2.4 million for the thr...

Arctic Vision announces exclusive licensing agreement with ActualEyes

2021-05-14 20:00 2788

To develop and commercialize cell therapy to potentially replace corneal endothelial keratoplasty inGreater China and South Korea * Arctic Vision to partner with ActualEyes to introduce novel approach of using cultured corneal endothelial cells to treat corneal endothelial dysfunction and pote...

Luye Life Sciences Unveils Cutting-edge Advances in Gene and Cell Therapy at ASGCT 2021

2021-05-14 11:58 1844

BOSTON, May 13, 2021 /PRNewswire/ -- The Boston R&D Center and GeneLeap Biotech, two subsidiaries of Luye Life Sciences Group, took part in the 24th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting, presenting the progress of four of the company's latest preclinical developments in ...

myMedidata Wins 'Best Patient Portal' Award in 2021 MedTech Breakthrough Awards Program

2021-05-14 11:00 2622

SINGAPORE, May 14, 2021 /PRNewswire/ -- Medidata , a Dassault Systèmes company, the global leader in creating end-to-end solutions supporting the entire clinical trial process, today announced that its  myMedidata

Antengene Announces the Completion of Its Manufacturing Center in Shaoxing to Accelerate the Commercialization of Novel Anti-Cancer Therapies

2021-05-14 08:00 3775

SHANGHAI and HONG KONG, May 14, 2021 /PRNewswire/ -- Today, Antengene Corporation Limited ("Antengene", SEHK: 6996.HK) successfully hosted an inauguration ceremony for its manufacturing center at the Binhai Life Science and Healthcare Industrial Zone in Shaoxing. The completion of the manufacturi...

I-Mab Added to MSCI China Index

2021-05-13 20:00 4970

SHANGHAI and GAITHERSBURG, Md., May 13, 2021 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that I-Mab has been selected for inclusion in the MSCI Ch...

An oral antiviral drug from Korea may be a problem solver for COVID-19

2021-05-13 16:37 1550

SEOUL, South Korea, May 13, 2021 /PRNewswire/ -- Hyundai Bioscience (KOSDAQ 048410) announced that Dr.Jin-Ho Choi, a Chief Scientist of its major shareholding bio tech company CNPharm and Chair Professor at Dankook University, presented the study titled 'COVID-19 Game Changer Drug – a novel orga...

Pregene and Dr. Reddy's Announce License Agreement for Anti-BCMA CAR-T PRG1801 in India

2021-05-13 15:21 1446

BEIJING, May 13, 2021 /PRNewswire/ -- Beijing Time May 10, 2021 — Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY) and Shenzhen Pregene Biopharma Co., Ltd. today announced an agreement whereby Dr Reddy's will acquire an exclusive license in the Republic ofInd...

Ascentage Pharma (6855.HK) Becomes a Constituent of MSCI China Small Cap Index

2021-05-13 08:28 1765

SUZHOU, China and ROCKVILLE, Md., May 13, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that according to the latest ...

1 ... 147148149150151